| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Stephen Mandia last filed a Form 4 in May 2015, as Director at CNMD. Stephen Mandia's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1 shares of CNMD. The CNMD filings lean toward selling, a net 22,399 shares.
Stephen Mandia has 3 Form 4 filings on record from April 2015 to May 2015, all as Director at Conmed (CNMD), 2015.
The 5 reported transactions were 5 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $1.2M.
The largest open-market sale was 14,000 shares of CNMD at an average $55.62 on May 29, 2015, about $779K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.